- Home
- FMST vs ECOR Comparison
FMST vs ECOR Comparison
Compare FMST & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMST
- ECOR
- Stock Information
- Founded
- FMST 2005
- ECOR 2005
- Country
- FMST Canada
- ECOR United States
- Employees
- FMST N/A
- ECOR N/A
- Industry
- FMST Other Metals and Minerals
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FMST Basic Materials
- ECOR Health Care
- Exchange
- FMST Nasdaq
- ECOR Nasdaq
- Market Cap
- FMST 38.2M
- ECOR 39.6M
- IPO Year
- FMST N/A
- ECOR 2018
- Fundamental
- Price
- FMST $2.43
- ECOR $5.85
- Analyst Decision
- FMST
- ECOR Strong Buy
- Analyst Count
- FMST 0
- ECOR 2
- Target Price
- FMST N/A
- ECOR $25.50
- AVG Volume (30 Days)
- FMST 381.6K
- ECOR 77.4K
- Earning Date
- FMST 11-12-2025
- ECOR 11-05-2025
- Dividend Yield
- FMST N/A
- ECOR N/A
- EPS Growth
- FMST N/A
- ECOR N/A
- EPS
- FMST N/A
- ECOR N/A
- Revenue
- FMST N/A
- ECOR $29,835,000.00
- Revenue This Year
- FMST N/A
- ECOR $24.55
- Revenue Next Year
- FMST N/A
- ECOR $41.13
- P/E Ratio
- FMST N/A
- ECOR N/A
- Revenue Growth
- FMST N/A
- ECOR 27.90
- 52 Week Low
- FMST $0.55
- ECOR $4.16
- 52 Week High
- FMST $5.74
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- FMST 35.87
- ECOR 57.90
- Support Level
- FMST $2.54
- ECOR $4.47
- Resistance Level
- FMST $2.85
- ECOR $6.61
- Average True Range (ATR)
- FMST 0.30
- ECOR 0.42
- MACD
- FMST -0.10
- ECOR 0.12
- Stochastic Oscillator
- FMST 8.54
- ECOR 60.63
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.